The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
Open accessAbstract
Despite international efforts to ‘roll back malaria’ the 2008 World Malaria Report revealed the disease still affects approximately 3 billion people in 109 countries; 45 within the WHO African region. The latest report however does provide some ‘cautious optimism’; more than one third of malarious countries have documented greater than 50% reductions in malaria cases in 2008 compared to 2000. The goal of the Member States at the World Health Assembly and ‘Roll Back Malaria’ (RBM) partnership is to reduce the numbers of malaria cases and deaths recorded in 2000 by 50% or more by the end of 2010. Although malaria is preventable it is most prevalent in poorer countries where prevention is difficult and prophylaxis is generally not an option. The burden of disease has increased by the emergence of multi drug resistant (MDR) parasites which threatens the use of established and cost effective antimalarial agents. After a major change in treatment policies, artemisinins are now the frontline treatment to aid rapid clearance of parasitaemia and quick resolution of symptoms. Since artemisinin and its derivatives are eliminated rapidly, artemisinin combination therapies (ACT’s) are now recommended to delay resistance mechanisms. In spite of these precautionary measures reduced susceptibility of parasites to the artemisinin-based component of ACT’s has developed at the Thai-Cambodian border, a historical ‘hot spot’ for MDR parasite evolution and emergence. This development raises serious concerns for the future of the artemsinins and this is not helped by controversy related to the mode of action. Although a number of potential targets have been proposed the actual mechanism of action remains ambiguous. Interestingly, artemisinins have also shown potent and broad anticancer properties in cell lines and animal models and are becoming established as anti-schistosomal agents. In this review we will discuss the recent evidence explaining bioactivation and potential molecular targets in the chemotherapy of malaria and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Self-citationThe structure of malaria pigment β-haematin
Pagola, S., Stephens, P. W., Bohle, D. S., Kosar, A. D., & Madsen, S. K. (2000) · Nature · doi:10.1038/35005132 · Cited by 860
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Molecular Modes of Action of Artesunate in Tumor Cell Lines
Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H. O., Hengstler, J. G., Halatsch, M.-E., Volm, M., Tew, K. D., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.382 · Cited by 428
Artemisinins: their growing importance in medicine
Krishna, S., Bustamante, L., Haynes, R. K., & Staines, H. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.004 · Cited by 388
Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)
Meshnick, S. R., Yang, Y. Z., Lima, V, Kuypers, F., Kamchonwongpaisan, S., & Yuthavong, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1108 · Cited by 327
Yeast Model Uncovers Dual Roles of Mitochondria in the Action of Artemisinin
Li, W., Mo, W., Shen, D., Sun, L., Wang, J., Lu, S., Gitschier, J. M., & Zhou, B. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010036 · Cited by 304
Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action
Meshnick, S. R., Thomas, A., Ranz, A., Xu, C.-M., & Pan, H.-Z. (1991) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(91)90062-b · Cited by 303
Terkuile, F., White, N. J., Holloway, P., Pasvol, G., & Krishna, S. (1993) · Experimental Parasitology · doi:10.1006/expr.1993.1010 · Cited by 290
Cytotoxicity of Artemisinin-Related Endoperoxides to Ehrlich Ascites Tumor Cells
Woerdenbag, H. J., Moskal, T. A., Pras, N., Malingré, T. M., El-Feraly, F. S., Kampinga, H. H., & Konings, A. W. T. (1993) · Journal of Natural Products · doi:10.1021/np50096a007 · Cited by 278
Efferth, T. (2007) · Planta Medica · doi:10.1055/s-2007-967138 · Cited by 269
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
Efferth, T., Benakis, A., Romero, M. R., Tomicic, M., Rauh, R., Steinbach, D., Häfer, R., Stamminger, T., Oesch, F., Kaina, B., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.023 · Cited by 266
Bhisutthibhan, J., Pan, X.-Q., Hossler, P. A., Walker, D. J., Yowell, C. A., Carlton, J., Dame, J. B., & Meshnick, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16192 · Cited by 263
Molecular Pharmacology and Pharmacogenomics of Artemisinin and its Derivatives in Cancer Cells
Efferth, T. (2006) · Current Drug Targets · doi:10.2174/138945006776359412 · Cited by 262
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins
Uhlemann, A.-C., Cameron, A., Eckstein-Ludwig, U., Fischbarg, J., Iserovich, P., Zuniga, F. A., East, M., Lee, A., Brady, L., Haynes, R. K., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb947 · Cited by 256
Pandey, A. V., Tekwani, B. L., Singh, R. L., & Chauhan, V. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19383 · Cited by 241
Posner, G. H., & O’Neill, P. M. (2004) · Accounts of Chemical Research · doi:10.1021/ar020227u · Cited by 237
Self-citationReaction of antimalarial endoperoxides with specific parasite proteins
Asawamahasakda, W., Ittarat, I., Pu, Y. M., Ziffer, H., & Meshnick, S. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1854 · Cited by 234
The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?
Kwok, J. C., & Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00213-x · Cited by 215 · cited 1×
“Selective activation of artemisinin by tumor cells has led to proposal of an iron dependent hypothesis due to the understanding that tumor cells maintain a high intracellular iron concentration to sustain continued proliferation in addition to an increased capacity to synthesize heme [43].”
BackgroundBakar, N. A., Klonis, N., Hanssen, E., Chan, C., & Tilley, L. (2010) · Journal of Cell Science · doi:10.1242/jcs.061499 · Cited by 204
Afonso, A., Hunt, P., Cheesman, S., Alves, A. C., Cunha, C. V., do Rosário, V., & Cravo, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.480-489.2006 · Cited by 203
Woodrow, C. J., Haynes, R. K., & Krishna, S. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.028399 · Cited by 203
Artesunate Derived from Traditional Chinese Medicine Induces DNA Damage and Repair
Li, P. C. H., Lam, E., Roos, W. P., Zdzienicka, M. Z., Kaina, B., & Efferth, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2970 · Cited by 200
Posner, G. H., & Oh, C. H. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00047a076 · Cited by 193
Mercer, A. E., Maggs, J. L., Sun, X.-M., Cohen, G. M., Chadwick, J., O'Neill, P. M., & Park, B. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610375200 · Cited by 192
Self-citationRecent advances in understanding the mechanism of hemozoin (malaria pigment) formation
Egan, T. J. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.12.004 · Cited by 190
The antimalarial drug artemisinin alkylates heme in infected mice
Robert, A., Benoit-Vical, F., Claparols, C., & Meunier, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500972102 · Cited by 190
Posner, G. H., Oh, C. H., Wang, D., Gerena, L., Milhous, W. K., Meshnick, S. R., & Asawamahasadka, W. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00035a003 · Cited by 188
Wu, W.-M., Wu, Y., Wu, Y.-L., Yao, Z.-J., Zhou, C.-M., Li, Y., & Shan, F. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973080o · Cited by 175
Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
EFFERTH, T. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.04.003 · Cited by 169
Hartwig, C. L., Rosenthal, A. S., D’Angelo, J. G., Griffin, C. E., Posner, G. H., & Cooper, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.015 · Cited by 147
Stocks, P. A., Bray, P. G., Barton, V., Al‐Helal, M., Jones, M., Araújo, N., Gibbons, P. D., Ward, S. A., Hughes, R. H., Biagini, G. A., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604697 · Cited by 140
Self-citationPosner, G. H., Wang, D., Cumming, J. N., Oh, C. H., French, A. N., Bodley, A. L., & Shapiro, T. A. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00013a001 · Cited by 133
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs
Skinner‐Adams, T. S., Manning, L. S., Johnston, W. A., & Davis, T. M. E. (1996) · International Journal for Parasitology · doi:10.1016/0020-7519(96)89380-5 · Cited by 131
Crespo, M. D. P., Avery, T. D., Hanssen, E. G., Fox, E., Robinson, T. V., Valente, P., Taylor, D. K., & Tilley, L. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00609-07 · Cited by 130
Alkylation of proteins by artemisinin
Yang, Y., Little, B., & Meshnick, S. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90287-9 · Cited by 124
Haynes, R. K., Chan, W. C., Lung, C., Uhlemann, A., Eckstein, U., Taramelli, D., Parapini, S., Monti, D., & Krishna, S. (2007) · ChemMedChem · doi:10.1002/cmdc.200700108 · Cited by 123
Stereochemistry-Dependent Cytotoxicity of Some Artemisinin Derivatives
Beekman, A. C., Barentsen, A. R. W., Woerdenbag, H. J., van Uden, W., Pras, N., Konings, A. W. T., El‐Feraly, F. S., Galal, A. M., & Wikström, H. (1997) · Journal of Natural Products · doi:10.1021/np9605495 · Cited by 118
Kumar, N., & Zheng, H. (1990) · Parasitology Research · doi:10.1007/bf00930817 · Cited by 118
Efferth, T., & Oesch, F. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.003 · Cited by 116
Creek, D. J., Charman, W. N., Chiu, F. C. K., Prankerd, R. J., Dong, Y., Vennerstrom, J. L., & Charman, S. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01033-07 · Cited by 115
Kelter, G., Steinbach, D., Konkimalla, V. B., Tahara, T., Taketani, S., Fiebig, H., & Efferth, T. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000798 · Cited by 112
Stockwin, L. H., Han, B., Yu, S. X., Hollingshead, M. G., ElSohly, M. A., Gul, W., Slade, D., Galal, A. M., & Newton, D. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24496 · Cited by 105
Kim, H., Shibata, Y., Wataya, Y., Tsuchiya, K., Masuyama, A., & Nojima, M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990014j · Cited by 105
Jefford, C. W., Vicente, M. G. H., Jacquier, Y., Favarger, F., Mareda, J., Millasson, P., Brunner, G., & Bürger, U. (1996) · Helvetica Chimica Acta · doi:10.1002/hlca.19960790520 · Cited by 98
The behaviour of qinghaosu (artemisinin) in the presence of heme iron(II) and (III)
Haynes, R. K., & Vonwiller, S. C. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(95)02141-8 · Cited by 98
Beekman, A. C., Wierenga, P. K., Woerdenbag, H. J., et al. (1998) · Planta Medica · doi:10.1055/s-2006-957533 · Cited by 97
Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target
Zhang, S., & Gerhard, G. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007472 · Cited by 96
Butler, A. R., Gilbert, B. C., Hulme, P., Irvine, L. R., Renton, L. F., & Whitwood, A. C. (1998) · Free Radical Research · doi:10.3109/10715769809066884 · Cited by 94
Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin
Zhang, S., & Gerhard, G. S. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.02.034 · Cited by 93
In Vitro Inhibition of Toxoplasma gondii by Four New Derivatives of Artemisinin
Jones‐Brando, L. V., D’Angelo, J. G., Posner, G. H., & Yolken, R. H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00793-06 · Cited by 89
Role of antioxidant genes for the activity of artesunate against tumor cells
Efferth, T., Briehl, M. M., & Tome, M. E. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.4.1231 · Cited by 88
Youns, M., Efferth, T., Reichling, J., Fellenberg, K., Bauer, A. S., & Hoheisel, J. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.014 · Cited by 88
Alkylation of human albumin by the antimalarial artemisinin
Yang, Y., Asawamahasakda, W., & Meshnick, S. R. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90425-v · Cited by 84
Iron chelators can protect against oxidative stress through ferryl heme reduction
Reeder, B. J., Hider, R. C., & Wilson, M. T. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.006 · Cited by 79
Artemisinin Antimalarials Do Not Inhibit Hemozoin Formation
Haynes, R. K., Monti, D., Taramelli, D., Basilico, N., Parapini, S., & Olliaro, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1175.2003 · Cited by 79
Case Report of a Pituitary Macroadenoma Treated With Artemether
Singh, N. P., & Panwar, V. K. (2006) · Integrative Cancer Therapies · doi:10.1177/1534735406295311 · Cited by 77
Mechanism of Antimalarial Action of the Synthetic Trioxolane RBX11160 (OZ277)
Uhlemann, A., Wittlin, S., Matile, H., Bustamante, L. Y., & Krishna, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01064-06 · Cited by 77
Haynes, R. K., Pai, H. H., & Voerste, A. A. W. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)00830-8 · Cited by 74
Immunomodulatory Activity of Boswellic Acids (Pentacyclic Triterpene Acids) fromBoswellia serrata
Sharma, M., Kaul, A., Khajuria, A., Singh, S. K., & Singh, G. B. (1996) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199603)10:2<140::aid-ptr792>3.0.co;2-d · Cited by 67
Jung, M., Kim, H., Nam, K. Y., & No, K. T. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.041 · Cited by 65
The behaviour of qinghaosu (artemisinin) in the presence of non-heme iron(II) and (III)
Haynes, R. K., & Vonwiller, S. C. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(95)02142-6 · Cited by 65
Jefford, C. W., Favarger, F., Vicente, M. G. H., & Jacquier, Y. (1995) · Helvetica Chimica Acta · doi:10.1002/hlca.19950780216 · Cited by 64
Reeder, B. J., & Wilson, M. T. (2005) · Chemical Research in Toxicology · doi:10.1021/tx049660y · Cited by 47
The Antimalarial Trioxaquine DU1301 Alkylates Heme in Malaria-Infected Mice
Garah, F. E., Claparols, C., Benoit‐Vical, F., Meunier, B., & Robert, A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-08 · Cited by 43
Garah, F. B.-E., Stigliani, J., Coslédan, F., Meunier, B., & Robert, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900200 · Cited by 34
Effect of artesunate on immune cells in ret-transgenic mouse melanoma model
Ramacher, M., Umansky, V., & Efferth, T. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330caba · Cited by 32
Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid
Kumura, N., Furukawa, H., Onyango, A. N., Izumi, M., Nakajima, S., Ito, H., Hatano, T., Kim, H., Wataya, Y., & Baba, N. (2009) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2009.04.005 · Cited by 26
Alkylation of heme by artemisinin, an antimalarial drug
Cazelles, J., Robert, A., & Meunier, B. (2001) · Comptes Rendus de l Académie des Sciences - Series IIC - Chemistry · doi:10.1016/s1387-1609(00)01188-9 · Cited by 26
Stocks, P. A., Bray, P. G., Barton, V., Al‐Helal, M., Jones, M., Araújo, N., Gibbons, P. D., Ward, S. A., Hughes, R. H., Biagini, G. A., et al. (2007) · Angewandte Chemie · doi:10.1002/ange.200604697 · Cited by 25
Self-citation
Cited by
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Graves, D. B. (2012) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/45/26/263001 · Cited by 1,518
Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., Sun, J.-N., Ma, D.-L., Han, Y.-F., Fong, W.-F., et al. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/627375 · Cited by 687
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Wang, J., Zhang, C.-J., Chia, W. N., Loh, C. C. Y., Li, Z., Lee, Y. M., He, Y., Yuan, L.-X., Lim, T. K., Liu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10111 · Cited by 633
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Chen, G.-Q., Benthani, F. A., Wu, J., Liang, D., Bian, Z.-X., & Jiang, X. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0352-3 · Cited by 509
Metadata
- Authors
- O’Neill, P. M., Barton, V. E., & Ward, S. A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2010-03-12
- Volume
- 15
- Issue
- 3
- Pages
- 1705-1721
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2074749191
- Cited by
- 595
- References
- 70
- FWCI
- 36.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.